4/21
04:05 pm
ocs
Oculis Publishes Invitation to the Annual General Meeting
Low
Report
Oculis Publishes Invitation to the Annual General Meeting
4/20
12:44 pm
ocs
Oculis (OCS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $44.00 price target on the stock.
Low
Report
Oculis (OCS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $44.00 price target on the stock.
4/20
04:17 am
ocs
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema [Yahoo! Finance]
Medium
Report
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema [Yahoo! Finance]
4/20
04:00 am
ocs
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
Medium
Report
Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema
4/7
04:00 am
ocs
Oculis to Participate in Upcoming Investor Conferences
Low
Report
Oculis to Participate in Upcoming Investor Conferences
3/31
05:11 am
ocs
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis [Yahoo! Finance]
Medium
Report
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis [Yahoo! Finance]
3/31
05:05 am
ocs
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis [TheStreet.com]
Medium
Report
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis [TheStreet.com]
3/31
04:00 am
ocs
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis
Medium
Report
Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First-in-Class Neuroprotective Candidate for Optic Neuritis
3/16
05:00 am
ocs
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
Low
Report
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
3/8
08:03 pm
ocs
Oculis Holding (NasdaqGM:OCS) Valuation Check After Strong Three Year Gains And Recent Share Price Pullback [Yahoo! Finance]
Medium
Report
Oculis Holding (NasdaqGM:OCS) Valuation Check After Strong Three Year Gains And Recent Share Price Pullback [Yahoo! Finance]
3/7
02:59 am
ocs
Medium
Report
3/5
04:00 am
ocs
Oculis to Participate in Upcoming Investor Conferences
Low
Report
Oculis to Participate in Upcoming Investor Conferences
3/4
09:09 pm
ocs
Oculis (OCS) was given a new $50.00 price target by Stifel Nicolaus.
Low
Report
Oculis (OCS) was given a new $50.00 price target by Stifel Nicolaus.
3/4
12:36 pm
ocs
Oculis (OCS) had its price target raised by HC Wainwright from $42.00 to $44.00. They now have a "buy" rating on the stock.
Low
Report
Oculis (OCS) had its price target raised by HC Wainwright from $42.00 to $44.00. They now have a "buy" rating on the stock.
3/4
08:00 am
ocs
Oculis (OCS) had its price target raised by Needham & Company LLC from $36.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Oculis (OCS) had its price target raised by Needham & Company LLC from $36.00 to $40.00. They now have a "buy" rating on the stock.
3/3
05:02 pm
ocs
Oculis Holding GAAP EPS of CHF -0.42 beats by $0.11 [Seeking Alpha]
Low
Report
Oculis Holding GAAP EPS of CHF -0.42 beats by $0.11 [Seeking Alpha]
3/3
04:34 pm
ocs
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update [Yahoo! Finance]
Low
Report
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update [Yahoo! Finance]
3/3
04:05 pm
ocs
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
Low
Report
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update
3/2
07:42 am
ocs
Earnings To Watch: Oculis Holding AG (OCS) Reports Q4 2025 Result [Yahoo! Finance]
Low
Report
Earnings To Watch: Oculis Holding AG (OCS) Reports Q4 2025 Result [Yahoo! Finance]
2/17
04:00 am
ocs
Oculis Appoints Katie Kazem as Chief Legal Officer
Low
Report
Oculis Appoints Katie Kazem as Chief Legal Officer